Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.
about
Iron dysregulation in Huntington's diseaseActivators of G protein signaling exhibit broad functionality and define a distinct core signaling triadReinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.Rhes suppression enhances disease phenotypes in Huntington's disease micePreclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction.Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington's disease in ratsGolgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease.RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum.Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease.mTOR in Brain Physiology and Pathologies.Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.Huntington's Disease in Arab Countries.RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitorA short history of the notion of neurodegenerative disease.Neuroprotective potential of antioxidant potent fractions from Convolvulus pluricaulis Chois. in 3-nitropropionic acid challenged rats.
P2860
Q26829932-D03580A0-CB57-46AD-9610-4EA14E8BED77Q26999408-13E7138B-71F1-4520-B0CD-F212A1ADE17DQ27306293-7A525332-CD5C-494E-91E1-9176DE802703Q33831774-232090B9-C31F-49F0-97A3-CFC6D8BCC28EQ34071922-7CCC5339-DFC1-4367-893E-17A93A073415Q34284039-760584F9-07ED-4E49-92EC-85C321A03B14Q34295237-1C7252F9-443E-49B0-A049-6AD99FB1ED17Q36078124-C023B83E-2AA9-4E60-A3E4-E6AA66A64C2DQ37241010-F3541038-B809-46DF-9396-E32416AA3CD6Q37482165-545A38F4-2684-458A-AC92-88D006A2D95AQ37563505-12015C21-FE97-4063-A903-42F43D83040CQ38447132-D13CF43C-2704-423F-B8FF-B4F3EF997202Q38565769-293CEF65-C87F-4B17-B390-102E2BBAD336Q38662191-C7D79263-82E9-441B-9768-FF57314D84FFQ39203917-9209DF63-C413-4C63-A143-98A1546137B0Q41140252-9AE1C129-A7AF-4546-9AA8-1CE7C3CCB366Q43500630-DF9ECAA5-51C1-430F-903A-06128045DAA3Q45305425-1CB09D42-C513-4487-95A9-A684DBD447C6
P2860
Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Rhes deletion is neuroprotecti ...... model of Huntington's disease.
@en
type
label
Rhes deletion is neuroprotecti ...... model of Huntington's disease.
@en
prefLabel
Rhes deletion is neuroprotecti ...... model of Huntington's disease.
@en
P2860
P1476
Rhes deletion is neuroprotecti ...... model of Huntington's disease.
@en
P2093
Robert G Mealer
Srinivasa Subramaniam
P2860
P304
P356
10.1523/JNEUROSCI.3730-12.2013
P407
P577
2013-02-01T00:00:00Z